Search Within

Andromachi Scaradavou

Formats
  1. Meeting Abstract (153)
  2. Journal Article (72)
  3. Research Letter (6)
  4. Book Section (5)
  5. Correspondence (3)
  6. Editorial (3)
  7. Review (3)
  8. Guidelines (1)
Groups
  1. Pediatrics, Department of (246)
  2. Stem Cell Transplantation and Cellular Therapy Service (246)
  3. Department of Medicine (217)
  4. Center for Hematologic Malignancies (199)
  5. Hematologic Malignancies, Division of (174)
  6. Bone Marrow Transplant (170)

More Groups

People
  1. Nancy Kernan (151)
  2. Juliet Barker (143)
  3. Richard O'Reilly (110)
  4. Sergio Giralt (101)
  5. Susan Prockop (92)
  6. Esperanza Papadopoulos (90)

More People

Years
  1. 2025 (8)
  2. 2024 (10)
  3. 2023 (17)
  4. 2022 (11)
  5. 2021 (6)
  6. 2020 (14)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (88)
  2. Blood (79)
  3. Bone Marrow Transplantation (21)
  4. Blood Advances (14)
  5. Transplantation and Cellular Therapy (9)
  6. Cytotherapy (6)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. American Society of Hematology (93)
  3. Nature Publishing Group (22)
  4. Elsevier Science Ltd. (6)
  5. John Wiley & Sons (5)
  6. Wiley Periodicals, Inc (4)

More Publishers

Results (246)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Analysis of 608 umbilical cord blood (UCB) transplants: HLA-match is a critical determinant of transplant-related mortality (TRM) in the post-engraftment period even in the absence of acute graft-vs-host disease (AGVHD)
    Meeting Abstract

    Barker, J.; Scaradavou, A.; Stevens, C.; Rubinstein, P.
    Biology of Blood and Marrow Transplantation (2006)

    Fulltext@MSK | Save
  • Allogeneic or autologous stem cell transplantation (SCT) for the treatment of pediatric patients with non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Ricafort, R.; Trippett, T.; Kernan, N. A.; Small, T. N.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.; Boulad, F.
    Blood (2005)

    Fulltext@MSK | Save
  • High dose Busulfan and fFludarabine with anti-thymocyte globulin (ATG) followed by unmodified marrow grafts from HLA-matched siblings for the treatment of high risk hemoglobinopathies (HGBpathies)
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Small, T. N.; Chewning, J.; Prockop, S.; Scaradavou, A.; Keating, A.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Analysis of 608 umbilical cord blood (UCB) transplants: HLA-match is a critical determinant of transplant-related mortality (TRM) in the post-engraftment period even in the absence of acute graft-vs-host disease (aGVHD)
    Meeting Abstract

    Barker, J. N.; Scaradavou, A.; Stevens, C. E.; Rubinstein, P.
    Blood (2005)

    Fulltext@MSK | Save
  • A murine model of cord blood transplantation
    Meeting Abstract

    Scaradavou, A.; Isola, L.; Rubinstein, P.; Galperin, Y.; Gordon, J.; Berlin, D.; Weinberg, R. S.
    Blood (1994)

    Fulltext@MSK | Save